CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0320
-0.0023 (-6.71%)
At close: Apr 27, 2026

CERO Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
111269236223
Market Cap Growth
-48.12%-87.73%-83.24%-70.89%6.05%-
Enterprise Value
891470236-
Last Close Price
0.030.07120.0022000.0020540.6019820.00
PB Ratio
-0.22-0.26-6.081574.06-21.45-29.01
Debt / Equity Ratio
-0.13-0.13-0.8367.45-0.06-
Net Debt / Equity Ratio
0.160.160.8932.60-0.020.14
Net Debt / EBITDA Ratio
0.050.050.11-0.20--
Quick Ratio
0.180.180.440.430.0211.20
Current Ratio
0.300.300.500.561.3813.88
Return on Assets (ROA)
-253.00%-253.00%-178.66%-20.20%-1.63%-
Return on Capital Employed (ROCE)
366.00%366.00%1355.00%-474.00%-25.00%-0.30%
Earnings Yield
-7892.28%-1409.96%-72.13%-10.61%-0.28%-0.24%
Buyback Yield / Dilution
-16477.89%-16477.89%----
Source: S&P Global Market Intelligence. Standard template. Financial Sources.